Licensing Red®/ET® Recombination
Gene Bridges GmbH owns the exclusive rights to Red/ET Recombination, a revolutionary DNA engineering technology. Gene Bridges issues licenses for the use of the Red/ET Recombination technology to commercial users. Licensing arrangements for Red/ET Recombination are provided as world-wide, non-exclusive sub-licenses.
6-Month Trial License
6-month trial licenses for EUR 3,500 are available for commercial parties wishing to test the technology.
Each license is provided with an attractive support package consisting of:- Control experiment and materials
- Detailed protocols
- All necessary sequence information
- Latest Red/ET Recombination plasmids regularly updated and supplied to licensee
- Red/ET Recombination proficient strains
Trial license: Eukaryotic applications
Trial license: Prokaryotic applications
Full License (standard format)
Gene Bridges can customize full licenses to include access to any combination of the following applications:
- Research only
- Cloning & Subcloning
- Knock-out & Knock-in constructs
- Transgenic constructs
- Conditional Knock-outs
- Viral engineering
- Transgenic Plants
They can be tailored to fit your requirements.
Full license: Eukaryotic applications
Full license: Prokaryotic applications
For more information about the licensing of Red/ET Recombination, please contact licenses@genebridges.com